source
- Roche announces drug that sets new benchmark for KRAS‑driven lung cancerRoche has announced a new therapy that it says establishes a new standard of care for patients with KRAS‑driven lung cancer. The announcement was featured in a STAT+ newsletter, underscoring the p…
- Biotech Index Surges 30% Year-to-Date as Market Rally AcceleratesMid-year data show the biotech sector continuing a strong rally that began in April 2025. The XBI index, the most-watched biotech gauge, rose 19% in June and is up about 30% for the year, trading…